pAAV-Ef1a-fDIO-tTA-P2A-TurboRFP-WPRE
(Plasmid
#257137)
-
PurposeCan be used as either a plasmid or a viral vector in combination with pAAV-TRE-Flpe-WPRE for Flpe-dependent sparse labeling.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 257137 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepAAV
- Total vector size (bp) 7105
-
Vector typeMammalian Expression, AAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nametTA-P2A-TurboRFP
-
SpeciesSynthetic
-
Insert Size (bp)1512
- Promoter EF1a
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site AscI (not destroyed)
- 5′ sequencing primer WPRE_R
- 3′ sequencing primer EF1a_F
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThe tTA-P2A-TurboRFP sequence was cloned from pK168.AAV-EF1a-DIO-tTA-P2A-RFP-WPRE (Addgene #85039) and the backbone was derived from pAAV-EF1a-fDIO-mCherry (Addgene #114471).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-Ef1a-fDIO-tTA-P2A-TurboRFP-WPRE was a gift from Kazutaka Ikeda (Addgene plasmid # 257137 ; http://n2t.net/addgene:257137 ; RRID:Addgene_257137) -
For your References section:
AAV-Based Bright and Sparse Labeling of Versatile Neurons Adaptable in Cre-Dependent Genetic Backgrounds. Kamijo S, Ikeda K, Miwa H. eNeuro. 2026 Mar 27;13(3):ENEURO.0314-25.2026. doi: 10.1523/ENEURO.0314-25.2026. Print 2026 Mar. 10.1523/ENEURO.0314-25.2026 PubMed 41839576